Increased glial metabolites predict increased working memory network activation in HIV brain injury.
Deficits in attention and working memory are common in human immuno deficiency virus type 1 (HIV-1)-infected patients, but the pathophysiology of these deficits is poorly understood. Modern neuroimaging techniques, such as proton magnetic resonance spectroscopy ((1)H MRS) and functional MRI (fMRI), can assess some of the processes underlying HIV brain injury. To evaluate the model that attentional deficits in early HIV brain disease are related to brain inflammation, (1)H MRS and fMRI were performed in 14 HIV-positive subjects [acquired immunodeficiency syndrome (AIDS) dementia complex stage 1 or less]. Increasing attentional load on three working memory tasks was assessed with fMRI, and the concentrations of brain metabolites were measured with (1)H MRS in the frontal gray and white matter, and basal ganglia. Metabolite concentrations were correlated with fMRI blood oxygenation level-dependent (BOLD) signals, using a random-effects linear regression model in SPM99. Several positive correlations were observed between the BOLD signal strength in the working memory network (posterior parietal cortex and lateral prefrontal cortex) and the concentrations of frontal white matter and basal ganglia metabolites that are predominant in glial cells (choline-containing compounds, myo-inositol, and total creatine). In contrast, BOLD signals in the working memory network were not correlated with the concentration of N-acetyl compounds, which are markers of neuronal viability, or with metabolite concentrations in the frontal gray matter. These findings are consistent with previous results that mild HIV brain injury is associated with increased glial activation without major involvement of neuronal abnormalities. We propose that the inflammatory glial abnormalities reduce the efficiency of neural processing, and necessitate compensatory increases in attention in patients, and associated BOLD signals, to perform a given task. The same mechanism may also contribute to cognitive dysfunction in other brain diseases that involve inflammation.
Ernst
T
T
Medical Department, Brookhaven National Laboratory, Building 490, P.O. Box 5000, Upton, NY 11973-5000, USA. TErnst@bnl.gov
Chang
L
L
Arnold
S
S
D015526:AIDS Dementia Complex / Q000503:physiopathology*; D000328:Adult; D001288:Attention / Q000502:physiology; D001479:Basal Ganglia / Q000503:physiopathology; D001931:Brain Mapping; D002794:Choline / Q000378:metabolism*; D003401:Creatine / Q000378:metabolism*; D005625:Frontal Lobe / Q000503:physiopathology; D015497:HIV-1; D006801:Humans; D007089:Image Enhancement; D007091:Image Processing, Computer-Assisted; D021621:Imaging, Three-Dimensional; D007294:Inositol / Q000378:metabolism*; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008570:Memory, Short-Term / Q000502:physiology; D008875:Middle Aged; D009457:Neuroglia / Q000502:physiology*; D010101:Oxygen Consumption / Q000502:physiology
D007294:Inositol; D003401:Creatine; D002794:Choline